SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
----------
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): March 5, 2004
-------------
E-Z-EM, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Delaware
----------------------------------------------
(State or Other Jurisdiction of Incorporation)
1-11479 11-1999504
------------------------ ---------------------------------
(Commission File Number) (IRS Employer Identification No.)
1111 Marcus Avenue, Lake Success, New York, NY 11042
---------------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
(516) 333-8230
----------------------------------------------------
(Registrant's telephone number, including area code)
ITEM 5. OTHER EVENTS AND REQUIRED FD DISCLOSURE
On March 5, 2004, AngioDynamics, Inc., E-Z-EM, Inc.'s wholly-owned
subsidiary, announced the filing of a registration statement with
the Securities and Exchange Commission for an initial public
offering of its common stock. A copy of the press release issued by
AngioDynamics is being filed as Exhibit 99.1 to this Form 8-K and is
incorporated herein by reference in its entirety.
SIGNATURES:
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: March 10, 2004 E-Z-EM, INC.
(Registrant)
By: /s/ Anthony A. Lombardo
---------------------------------
Anthony A. Lombardo
President and Chief Executive Officer
2
EXHIBIT INDEX
-------------
Number Description
------ -----------
Exhibit 99.1 AngioDynamics, Inc. press release.
3